BioWorld Science

Dec. 31, 2001

View Archived Issues

FDA approves insulin analogue for pump therapy

Read More

Positive phase I/II AlloMune results for end-stage lymphoma

Read More

Kyowa Hakko develops new antibody technology

Read More

GeneProt delivers potential protein candidates to Novartis

Read More

Preparation and use of new thienopyrimidinediones discovered at AstraZeneca

Read More

Uriach researchers identify selective COX-2 inhibitors with antiinflammatory activity

Read More

Schering discloses new series of antiangiogenic agents

Read More

Novel epothilone derivatives from Schering act as microtubule-stabilizing agents

Read More

Vancomycin analogues with activity against enterococci and staphylococci

Read More

Inhibitors of shikamate pathway enzyme under development at Arrow as novel antibiotics

Read More

Design and preclinical evaluation of a new class of bacterial peptide deformylase inhibitors

Read More

Oxapenem beta-lactamase inhibitors reported at ICAAC to extend spectrum of cephalosporins

Read More

MitoKor and Pfizer extend mitochondrial dysfunction collaboration

Read More

ISV-401 enters phase II trials for bacterial conjunctivitis

Read More

Schering and MorphoSys enter therapeutic and diagnostic R&D agreement

Read More

AHP and Elan form sleep disorder alliance

Read More

Preliminary preclinical data demonstrate tumor vascular targeting efficacy of OXI-4503

Read More

Celera and Syrrx enter structural proteomics collaboration

Read More